)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Asahi Intecc
Asahi Intecc (7747) investor relations material
Asahi Intecc Q1 2027 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 2027 earnings summary13 Nov, 2026
Executive summary
Q1 FY2027 net sales rose 21.3% YoY to ¥43,729 million; operating profit increased 34.8% to ¥17,569 million, and profit attributable to owners of parent rose 38.0% to ¥12,706 million.
Sales increased in both divisions and quarterly performance exceeded plan; FY2027 guidance remained unchanged pending review of distributor timing, FX and expense recognition.
Financial highlights
Gross profit increased 27.0% YoY to ¥32,307 million; gross margin rose to 73.9% from 70.5%.
Ordinary profit rose 39.0% to ¥17,909 million; basic EPS increased to ¥47.89 from ¥34.37.
Comprehensive income decreased 16.1% to ¥9,896 million, mainly due to a smaller foreign-currency translation adjustment.
SG&A rose to ¥14,737 million from ¥12,401 million; its sales ratio declined to 33.7% from 34.3%, and R&D expense was ¥3,252 million.
Outlook and guidance
FY2027 forecast unchanged: net sales ¥161,794 million, operating profit ¥52,127 million, ordinary profit ¥52,600 million and parent-attributable profit ¥37,832 million.
FY2027 basic EPS forecast is ¥142.59; Q1 sales and profit exceeded plan, but full-year effects of distributor timing, FX and expense recognition remain under review.
SG&A timing differences, mainly R&D expenses, affected Q1; expenses are expected to progress generally as planned for FY2027.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Asahi Intecc
- Raising 2030 targets, the plan accelerates global growth in high value-added medical devices.7747
Corporate presentation - Strong sales and profit growth driven by Medical and Device divisions and overseas demand.7747Q4 2026
- Operating profit up 45.5% and net income up 204.2% year-over-year, with strong outlook.7747Q3 2026
- Operating profit up 40.1% and EPS up 43.0% on strong sales and margin gains.7747Q2 2026
- Strong sales and profit growth, with improved margins and some European market uncertainty.7747Q1 2026
- Strong sales and profit growth led by Medical, but net income declined on impairment losses.7747Q4 2025
- Medical Division growth and margin gains drove strong profit increases; outlook steady.7747Q1 2025
- Record revenue and profit growth, with strong Medical Division performance and robust outlook.7747Q4 2024
- Strong sales and operating profit growth offset by major impairment losses.7747Q3 2025
Next Asahi Intecc earnings date
Q2 202712 Feb, 2027
Asahi Intecc
Next Asahi Intecc earnings date
Q2 202712 Feb, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Asahi Intecc Co., Ltd. is a Japanese company specializing in the development, manufacturing, and sale of medical devices and industrial components. Its primary products include ultra-fine stainless steel wire ropes, guide wires, and catheters used in various medical treatments, including cardiovascular, cerebrovascular, and peripheral vascular applications. The company also produces terminal-processed products and supplies high-function components for industrial equipment. The company is headquartered in Seto, Aichi, and its shares are listed on the Tokyo Stock Exchange.